Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure

NCT00662116 is registered in ClinicalTrials.gov with Synvista Therapeutics, Inc as lead sponsor.

NCT NCT00662116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00662116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure
Lead sponsor
Synvista Therapeutics, Inc
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2008
Completion date
December 31, 2009
Enrollment
160 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

diastolic heart failure